Startseite>>Signaling Pathways>> Membrane Transporter/Ion Channel>> P-glycoprotein>>(R)-Verapamil hydrochloride

(R)-Verapamil hydrochloride

Katalog-Nr.GC60408

(R)-Verapamilhydrochlorid ((R)-(+)-Verapamilhydrochlorid) ist ein P-Glycoprotein-Inhibitor. (R)-Verapamilhydrochlorid blockiert den MRP1-vermittelten Transport, was zu einer Chemosensibilisierung von MRP1-Überexprimierenden Zellen gegenÜber Krebsmedikamenten fÜhrt.

Products are for research use only. Not for human use. We do not sell to patients.

(R)-Verapamil hydrochloride Chemische Struktur

Cas No.: 38176-02-2

Größe Preis Lagerbestand Menge
5mg
185,00 $
Auf Lager
10mg
334,00 $
Auf Lager
50mg
1.020,00 $
Auf Lager
100mg
1.715,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs[1][2].

[1]. Plumb JA, et al. The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. Biochem Pharmacol. 1990 Feb 15;39(4):787-92. [2]. Perrotton T, et al. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J Biol Chem. 2007 Oct 26;282(43):31542-8. Epub 2007 Jul 22.

Bewertungen

Review for (R)-Verapamil hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-Verapamil hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.